News
1don MSN
Penn's Kiran Musunuru spoke with The Inquirer about the future of CRISPR technology.
U.S. regulators asked Sarepta Therapeutics on Friday to voluntarily halt shipments of its Elevidys gene therapy after a ...
It is trying to treat a devastating lifelong disease by fixing it at its source. We are able to fix the actual genetic ...
By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration is planning to ask Sarepta Therapeutics to voluntarily stop ...
Sarepta Therapeutics said on Monday that it will pause all shipments of its Elevidys gene therapy in the United States after a muscular dystrophy patient who received a different, experimental ...
The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% ...
Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million in Prime Medicine to continue ...
Scientists have corrected gene mutations in mice causing an ultra-rare disease by editing DNA directly in the brain with a ...
The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...
1d
News Medical on MSNGene editing in the brain offers hope for ultra-rare neurological diseaseScientists have corrected gene mutations in mice causing an ultra-rare disease by editing DNA directly in the brain with a ...
Prime editing corrects the most common genetic mutations that cause alternating hemiplegia of childhood (AHC), a rare and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results